TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medicure ( (TSE:MPH) ) has shared an announcement.
Medicure Inc. announced it will present its financial results for the quarter ended September 30, 2025, via a conference call on November 20, 2025. This announcement is significant for stakeholders as it provides insights into the company’s financial health and operational performance, potentially impacting its market positioning and investor confidence.
The most recent analyst rating on (TSE:MPH) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Medicure stock, see the TSE:MPH Stock Forecast page.
Spark’s Take on TSE:MPH Stock
According to Spark, TipRanks’ AI Analyst, TSE:MPH is a Neutral.
The overall stock score of 55 reflects a mixed outlook. The most significant factor is the company’s financial performance, which shows challenges in profitability and cash flow despite stable leverage. Technical analysis provides a more positive view with bullish indicators, but valuation concerns due to a negative P/E ratio weigh heavily on the score. The absence of earnings call and corporate events data limits additional insights.
To see Spark’s full report on TSE:MPH stock, click here.
More about Medicure
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of healthcare products for the U.S. market. It markets AGGRASTAT® (tirofiban hydrochloride) injection and ZYPITAMAG® (pitavastatin) tablets through its U.S. subsidiary, Medicure Pharma Inc. The company also operates Marley Drug Inc., a pharmacy servicing all 50 states, Washington D.C., and Puerto Rico, and Gateway Medical Pharmacy in Portland, Oregon, as well as West Olympia Pharmacy in Washington.
Average Trading Volume: 3,942
Technical Sentiment Signal: Hold
Current Market Cap: C$13.46M
Learn more about MPH stock on TipRanks’ Stock Analysis page.